Okay. Phase 1 trial, you say. A couple more such items in the news this week. One new FDA approval after a Phase 2 study, and one publication in Nature on a stu

Okay. Phase 1 trial, you say. A couple more such items in the news this week. One new FDA approval after a Phase 2 study, and one publication in Nature on a study in mice. https://scitechdaily.com/scientists-engineer-human-t-cells-100x-more-potent-at-killing-cancer-cells/ https://scitechdaily.com/scientists-engineer-human-t-cells-1... https://www.fda.gov/news-events/press-announcements/fda-approves-first-cellular-therapy-treat-patients-unresectable-or-metastatic-melanoma https://www.fda.gov/news-events/press-announcements/fda-appr...